Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec 27;11(1):27.
doi: 10.3390/antibiotics11010027.

Diagnostic Testing for Sepsis: A Systematic Review of Economic Evaluations

Affiliations
Review

Diagnostic Testing for Sepsis: A Systematic Review of Economic Evaluations

Paula Rojas-Garcia et al. Antibiotics (Basel). .

Abstract

Introduction: Sepsis is a serious and expensive healthcare problem, when caused by a multidrug-resistant (MDR) bacteria mortality and costs increase. A reduction in the time until the start of treatment improves clinical results. The objective is to perform a systematic review of economic evaluations to analyze the cost-effectiveness of diagnostic methods in sepsis and to draw lessons on the methods used to incorporate antimicrobial resistance (AMR) in these studies.

Material and methods: the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed, and the Consolidated Health Economic Evaluation Reporting standards (CHEERS) checklist was used to extract the information from the texts.

Results: A total of 16 articles were found. A decision model was performed in 14. We found two ways to handle resistance while modelling: the test could identify infections caused by a resistant pathogen or resistance-related inputs, or outcomes were included (the incidence of AMR in sepsis patients, antibiotic use, and infection caused by resistant bacterial pathogens).

Conclusion: Using a diagnostic technique to detect sepsis early on is more cost-effective than standard care. Setting a direct relationship between the implementation of a testing strategy and the reduction of AMR cases, we made several assumptions about the efficacy of antibiotics and the length-of-stay of patients.

Keywords: AMR; antibiotics; diagnostic testing; sepsis; systematic review.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PRISMA flow diagram.

Similar articles

Cited by

  • Biomarkers in pulmonary infections: a clinical approach.
    Póvoa P, Coelho L, Cidade JP, Ceccato A, Morris AC, Salluh J, Nobre V, Nseir S, Martin-Loeches I, Lisboa T, Ramirez P, Rouzé A, Sweeney DA, Kalil AC. Póvoa P, et al. Ann Intensive Care. 2024 Jul 17;14(1):113. doi: 10.1186/s13613-024-01323-0. Ann Intensive Care. 2024. PMID: 39020244 Free PMC article. Review.

References

    1. Teggert A., Datta H., Ali Z. Biomarkers for Point-of-Care Diagnosis of Sepsis. Micromachines. 2020;11:286. doi: 10.3390/mi11030286. - DOI - PMC - PubMed
    1. Rudd K.E., Johnson S.C., Agesa K.M., Shackelford K.A., Tsoi D., Kievlan D.R., Colombara D.V., Ikuta K.S., Kissoon N., Finfer S., et al. Global, regional, and national sepsis incidence and mortality, 1990–2017, analysis for the Global Burden of Disease Study. Lancet. 2020;395:200–211. doi: 10.1016/S0140-6736(19)32989-7. - DOI - PMC - PubMed
    1. Dupuis C., Bouadma L., Ruckly S., Perozziello A., Van-Gysel D., Mageau A., Mourvillier B., de Montmollin E., Bailly S., Papin G., et al. Sepsis and septic shock in France: Incidences, outcomes and costs of care. Ann. Intensive Care. 2020;10:145. doi: 10.1186/s13613-020-00760-x. - DOI - PMC - PubMed
    1. Torio C.M., Moore B.J. National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2013, Statistical Brief #204. Agency for Healthcare Research and Quality; Rockville, MD, USA: 2006. [(accessed on 24 November 2021)]. Available online: http://europepmc.org/abstract/MED/27359025. - PubMed
    1. Hadžić D., Skokić F., Brkić S., Saračević A., Softić D., Softić D. Epidemiology of neonatal sepsis caused by multidrug resistant pathogens in a neonatal intensive care unit level 3. Med. Glas. (Zenica) 2020;17:375–382. doi: 10.17392/1157-20. - DOI - PubMed

LinkOut - more resources